ECSP024342A - Nuevos derivados d e fenilpropargileter - Google Patents

Nuevos derivados d e fenilpropargileter

Info

Publication number
ECSP024342A
ECSP024342A EC2002004342A ECSP024342A ECSP024342A EC SP024342 A ECSP024342 A EC SP024342A EC 2002004342 A EC2002004342 A EC 2002004342A EC SP024342 A ECSP024342 A EC SP024342A EC SP024342 A ECSP024342 A EC SP024342A
Authority
EC
Ecuador
Prior art keywords
optionally substituted
alkyl
hydrogen
alkynyl
alkenyl
Prior art date
Application number
EC2002004342A
Other languages
English (en)
Inventor
Jurgen Dederichs
Thomas Rigassi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9924043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP024342(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP024342A publication Critical patent/ECSP024342A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a derivados de fenilpropargiléter de la fórmula genera 1 que incluye los isómeros ópticos de los mismos y las mezclas de tales isómeros, EN DONDE r1 ES Hidrógeno, alquilo, cicloalquilo a arilo opcionalmente sustituido, R2 y R3 son independientemente entre sí hidrógeno o alquilo, R4 es alquilo, alquenilo o alquinilo, R5, R6, R7 y R8 son independientemente entre sí, hidrógeno o alquilo, R9 es hidrógeno, alquilo opcionalmente sustituido, alquenilo opcionalmente sustituido o alquinilo opcionalmente sustituido, R10 o es arilo opcionalmente sustituido o heteroarilo opcionalmente sustituido, y Z es halógeno, ariloxilo opcionalmente sustituido, alcoxilo opcionalmente sustituido, alqueniloxilo opcionalmente sustituido, alquiniloxilo opcionalmente sustituido, ariltio opcionalmente sustituido, alquiltio opcionalmente sustituido, alqueniltio opcionlmente sustituido, alquiniltio opcionalmente sustuido, alquilsulfinilo opcionalmente sustituido, alquenilsulfinilo opcionalmente sustituido, alquinilsufinilo opcionalmente sustituido, alquilsulfonilo opcionalmente sustituido, alquenilsufonilo opcionalmente sustituido o alquinilsulfonilo opcionanalmente sustituido. Estos compuestos poseen propiedades protectoras útiles para plantas y pueden ser convenientemente empleados en la práctica de la agricultura, para el control y la prevención de la infección de plantas por microorganismos fitopatogenicos, especialmente hongos.
EC2002004342A 2001-10-17 2002-11-19 Nuevos derivados d e fenilpropargileter ECSP024342A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0124953.1A GB0124953D0 (en) 2001-10-17 2001-10-17 Organic Compounds

Publications (1)

Publication Number Publication Date
ECSP024342A true ECSP024342A (es) 2003-03-10

Family

ID=9924043

Family Applications (2)

Application Number Title Priority Date Filing Date
EC2002004342A ECSP024342A (es) 2001-10-17 2002-11-19 Nuevos derivados d e fenilpropargileter
EC2002004341A ECSP024341A (es) 2001-10-17 2002-11-19 Composiciones farmaceuticas

Family Applications After (1)

Application Number Title Priority Date Filing Date
EC2002004341A ECSP024341A (es) 2001-10-17 2002-11-19 Composiciones farmaceuticas

Country Status (31)

Country Link
US (3) US20050013859A1 (es)
EP (1) EP1438040B2 (es)
JP (2) JP2005508959A (es)
KR (1) KR100671367B1 (es)
CN (1) CN1310640C (es)
AR (2) AR036813A1 (es)
AT (1) ATE374023T1 (es)
AU (1) AU2002338897B2 (es)
BR (1) BR0213355A (es)
CA (1) CA2460574A1 (es)
CO (1) CO5390076A1 (es)
CY (1) CY1107841T1 (es)
DE (1) DE60222687T3 (es)
DK (1) DK1438040T4 (es)
EC (2) ECSP024342A (es)
ES (1) ES2292819T5 (es)
GB (1) GB0124953D0 (es)
HU (1) HU231114B1 (es)
IL (2) IL160968A0 (es)
MX (1) MXPA04003636A (es)
MY (1) MY139206A (es)
NO (1) NO341804B1 (es)
NZ (1) NZ532280A (es)
PE (1) PE20030476A1 (es)
PL (2) PL415001A1 (es)
PT (1) PT1438040E (es)
RU (2) RU2338528C2 (es)
SI (1) SI1438040T2 (es)
TW (1) TWI333861B (es)
WO (1) WO2003032978A1 (es)
ZA (1) ZA200401977B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
WO2006012379A2 (en) * 2004-07-20 2006-02-02 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Processes for preparation of crystalline mycophenolate sodium
GB0419355D0 (en) * 2004-08-31 2004-09-29 Novartis Ag Organic compounds
WO2006086498A2 (en) * 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors
EP1917010A2 (en) * 2005-02-08 2008-05-07 Aspreva Pharmaceuticals SA Compositions and methods for treating vascular, autoimmune and inflammatory diseases
AU2006297130B2 (en) * 2005-09-30 2009-12-24 Novartis Ag DPP IV inhibitor for use in the treatment of autoimmune diseases and graft rejection
EP1965760B1 (de) * 2005-12-21 2013-02-27 Basf Se Feinteiliges quervernetztes polyvinylpyrrolidon als tablettensprengmittel
CA2640283A1 (en) * 2006-02-13 2007-08-23 Novartis Ag High dosage of mycophenolic acid (mpa)
CN102083410B (zh) 2007-06-06 2013-04-17 巴斯夫欧洲公司 用于制备迅速崩解的片剂的药物制剂
CN101707930B (zh) 2007-06-06 2013-10-30 巴斯夫欧洲公司 用于制备快速崩解的片剂的药物配制剂
RU2010109408A (ru) * 2007-08-13 2011-09-20 Панацея Биотек Лимитед (In) Композиции с пролонгированным высвобождением, включающие микофенолят натрия, и их действия
CN101969931A (zh) * 2008-03-05 2011-02-09 万能药生物有限公司 包含霉酚酸的调节释放药物组合物及其方法
EP2310008A4 (en) * 2008-07-09 2014-03-05 Aspreva Internat Ltd MYCOPHENOLIC SODIUM ACID SOLUTIONS WITH PH SPECIFIC FOR THE TREATMENT OF OCULAR DISORDERS
EP2488173A1 (en) * 2009-10-13 2012-08-22 Teva Pharmaceutical Industries Ltd. Delayed release compositions
US20110086102A1 (en) * 2009-10-13 2011-04-14 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011051967A2 (en) * 2009-10-23 2011-05-05 Alkem Laboratories Ltd Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
GB201100786D0 (en) 2011-01-18 2011-03-02 Ems Sa Pharmaceutical compositions of immunosuppressants
CN102793658A (zh) * 2012-08-23 2012-11-28 无锡福祈制药有限公司 一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片
CN103845323B (zh) * 2012-11-30 2018-02-02 重庆华邦制药有限公司 麦考酚酸及其盐肠溶制剂和制备方法
WO2014167442A1 (en) 2013-03-26 2014-10-16 Wockhardt Limited Pharmaceutical compositions comprising mycophenolic acid or salts thereof
CN106727403A (zh) * 2017-01-03 2017-05-31 无锡福祈制药有限公司 一种麦考酚钠肠溶片及其制备方法
CN110662533A (zh) * 2017-03-13 2020-01-07 奥卡瓦制药公司 向非人哺乳动物递送霉酚酸活性剂的方法和组合物
EP3801542B1 (en) 2018-06-06 2022-08-10 Poxel SA Methods of treating subjects having diabetes with chronic kidney disease
JP7266616B2 (ja) 2018-06-14 2023-04-28 ポクセル 糖尿病の治療において使用するためのトリアジン誘導体を含むフィルムコーティング錠剤
RU2723255C2 (ru) * 2018-11-14 2020-06-09 Общество с ограниченной ответственностью "Изварино Фарма" Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
AU2021424131A1 (en) * 2021-01-28 2023-07-27 Priothera Limited Methods of treatment with s1p receptor modulators
TW202245741A (zh) * 2021-01-28 2022-12-01 法商普萊歐塞拉公司 使用s1p受體調節劑之治療方法
EP4346790A4 (en) * 2021-05-26 2025-04-16 The Texas A&M University System Biodegradable mucoadhesive pharmaceutical formulations and methods thereof
CN117442580B (zh) * 2023-12-21 2024-04-05 泊诺(天津)创新医药研究有限公司 一种高生物利用度麦考酚钠肠溶片及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157100A (en) † 1966-09-27 1969-07-02 Ici Ltd Pharmaceutical Compositions
GB1157099A (en) * 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1203328A (en) * 1968-06-04 1970-08-26 Ici Ltd Pharmaceutical compositions
US3705946A (en) * 1971-05-25 1972-12-12 Lilly Co Eli Method of treating hyperuricemia
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
JPS56127093A (en) * 1980-03-10 1981-10-05 Ajinomoto Co Inc Preparation of mycophenolic acid
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US5177072A (en) * 1987-01-30 1993-01-05 Syntex (U.S.A.) Inc. Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
WO1994012184A1 (en) * 1992-11-24 1994-06-09 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
EP0670724A1 (en) * 1992-11-24 1995-09-13 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
JP3725539B2 (ja) * 1993-02-26 2005-12-14 大正製薬株式会社 ビサコジル剤形
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
EP0721335B1 (en) * 1993-10-01 2005-08-31 Roche Palo Alto LLC Mycophenolate mofetil high dose oral suspensions
EP0724441A1 (en) * 1993-10-19 1996-08-07 The Procter & Gamble Company Picosulphate dosage form
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
AU4565000A (en) * 1999-05-10 2000-11-21 Novartis Ag Organic compounds
HUP9903226A2 (en) * 1999-09-23 2002-08-28 Gyogyszerki Process for producing mycophenolic acid and derivatives thereof
JP2003525052A (ja) * 2000-02-29 2003-08-26 バイオコン・インディア・リミテッド マイコフェノール酸の製造および精製
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
ECSP024341A (es) 2003-12-01
RU2007130786A (ru) 2009-02-20
MXPA04003636A (es) 2004-07-27
US20120237601A1 (en) 2012-09-20
TWI333861B (en) 2010-12-01
US20050013859A1 (en) 2005-01-20
GB0124953D0 (en) 2001-12-05
EP1438040B1 (en) 2007-09-26
HU231114B1 (hu) 2020-09-28
AU2002338897B2 (en) 2006-10-19
KR20050037409A (ko) 2005-04-21
CA2460574A1 (en) 2003-04-24
KR100671367B1 (ko) 2007-01-19
PL367738A1 (en) 2005-03-07
CN1310640C (zh) 2007-04-18
DK1438040T4 (da) 2020-01-27
AR085778A2 (es) 2013-10-30
CO5390076A1 (es) 2004-04-30
PL234541B1 (pl) 2020-03-31
WO2003032978A1 (en) 2003-04-24
HUP0600451A2 (en) 2006-09-28
JP2009137996A (ja) 2009-06-25
ZA200401977B (en) 2006-05-31
BR0213355A (pt) 2006-05-23
SI1438040T1 (sl) 2008-04-30
CY1107841T1 (el) 2013-06-19
EP1438040A1 (en) 2004-07-21
DE60222687T3 (de) 2020-03-05
RU2338528C2 (ru) 2008-11-20
HK1067861A1 (en) 2005-04-22
ES2292819T3 (es) 2008-03-16
MY139206A (en) 2009-08-28
JP2005508959A (ja) 2005-04-07
CN1564684A (zh) 2005-01-12
SI1438040T2 (sl) 2020-02-28
NZ532280A (en) 2007-05-31
US20100210717A1 (en) 2010-08-19
IL160968A0 (en) 2004-08-31
RU2381026C2 (ru) 2010-02-10
AR036813A1 (es) 2004-10-06
DE60222687D1 (de) 2007-11-08
IL160968A (en) 2016-04-21
PL415001A1 (pl) 2016-02-29
PE20030476A1 (es) 2003-07-30
DE60222687T2 (de) 2008-07-17
ES2292819T5 (es) 2020-05-29
ATE374023T1 (de) 2007-10-15
NO20041785L (no) 2004-05-03
NO341804B1 (no) 2018-01-22
DK1438040T3 (da) 2008-02-04
RU2004115332A (ru) 2005-04-20
EP1438040B2 (en) 2019-10-16
PT1438040E (pt) 2008-01-02

Similar Documents

Publication Publication Date Title
ECSP024342A (es) Nuevos derivados d e fenilpropargileter
HN2001000099A (es) Nuevos derivados del fenil-propargiileter
AR026915A1 (es) Novedosas pirazolcarboxamidas y pirazoltioamidas como fungicidas
BR0213010A (pt) Aminopirimidinas substituìdas com tiazolila como agentes de proteção de plantas
BR9405988A (pt) Derivados da dialotriazolpirimidina como fungicidas
TR200001435T2 (tr) Antimikrobiyal kuinolonlar, bunların bileşimleri ve kullanımları
AR037901A1 (es) Beta-amino-alfa-cianoacrilatos
PT718293E (pt) Composto ciclodepsipeptidico
AR037389A1 (es) Derivados de fenil-propargileter
KR930017894A (ko) 살충제 조성물
WO2002081437A3 (en) Novel n-p-propargyloxyphenethyl-thioacetic acid amides
AR054414A1 (es) Compuestos espiro-hidantoina sustituidos con piridilo. composiciones farmaceuticas.
BR1100427A (pt) Composto e processo para combater insetos, ácaros e moluscos, processo para proteger plantas em crescimento do ataque por insetos, ácaros e moluscos e composição para controlar insetos, ácaros e moluscos
BR0007822A (pt) Derivados de n-alcóxi-fenilcarbamatos
PE20030758A1 (es) 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion
BR1100430A (pt) Composto, processo e composição para controlar insetos, ácaros e moluscos e processo para proteger plantas em crescimento do ataque de insetos, ácaros e moluscos
BR1100421A (pt) Composto para controlar insetos, ácaros e moluscos, processo para controlar insetos, ácaros e moluscos, e, processo para proteger plantas em crescimento de ataque por insetos, ácaros e moluscos
BR0315122A (pt) Derivados de propargiléter para o controle de microorganismos fitopatogênicos
DOP2004000908A (es) Sulfonamidas ciclicas para la inhibicion de gamma secretasa